skip to main content

News Archive

Date: 11/27/2019
The six U-M Rogel Cancer Center members are: Dr. Maria G. Castro, Dr. Jun Li, Dr. Linda C. Samuelson, Dr. Emily E. Scott, Dr. Shaomeng Wang, Dr. Weiping Zou.
Date: 11/22/2019
Between 2005 and 2015, prescriptions for gabapentinoid medications -- gabapentin and pregabalin -- to adults with cancer saw a two-fold increase, a U-M Rogel Cancer Center study has found.
Date: 11/18/2019
STAT3 has been a major therapeutic target in the treatment of cancer. But it's largely been considered “undruggable” due to the difficulty of developing compounds to effectively inhibit its activity. Researchers at the U-M Rogel Cancer Center have a new approach to targeting STAT3.
Date: 11/16/2019
A group of researchers at the U-M Rogel Cancer Center is laying the foundations for a new, “multi-omic” approach that could help determine the drugs to which a particular triple-negative tumor will be most likely to respond based on the totality of its molecular features.
Date: 11/13/2019
Despite the fact that half of cervical cancers are diagnosed after age 49, participation in preventive screening steadily declines between ages 45 and 65.
Date: 11/04/2019
Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny “decoy” implanted just beneath the skin, University of Michigan researchers have demonstrated in mice.
Date: 11/02/2019
Within minutes of breaking a bone, the body begins to repair itself, But when that process is impaired by age, diabetes or radiation treatment for cancer, surgeons at Michigan Medicine are pioneering a device shown to accelerate bone regeneration.
Date: 10/30/2019
Although it may seem very beneficial to do everything possible to treat a disease, new research led by the Rogel Cancer Center shows that, in the case of long-term surveillance of treated, low-risk thyroid cancer, doing everything possible drives up cost without improving outcomes.
Date: 10/30/2019
Celina Kleer, M.D., the Harold A. Oberman Collegiate Professor of Pathology at the University of Michigan Medical School and member of the Rogel Cancer Center, will receive the 2019 AACR Outstanding Investigator Award for Breast Cancer Research, supported by the Breast Cancer Research Foundation.
Date: 10/28/2019
Rogel Cancer Center member and researcher Thomas Wang, M.D., Ph.D. is part of an interdepartmental team awarded by the National Institute for Health to study ways to improve endoscopy.

Pages